(Test Only) Increasing Testing Capacity for COVID-19 with Sherlock CRISPR-Based Diagnostics

CRISPR-based diagnostic methods are poised to have a significant impact on global health, and now, with the first FDA-emergency authorized use of CRISPR technology, this impact is being brought directly to the fight against the global COVID-19 pandemic. Join us to learn more about how Sherlock Biosciences has been driving CRISPR innovation and how that mission, with IDT's support, has led to the Sherlock™ CRISPR SARS-CoV-2 kit. Our speakers will provide an overview of SHERLOCK CRISPR technology and how it has been adapted for specific and sensitive detection of SARS-CoV-2 to increase testing capacity.